Clinical Trials
10 trialsNCT07191730 2026-03-19
ML-CardioTox
University Hospital, Caen
Recruiting
NCT05507879 2026-02-10
TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer
Mayo Clinic
Recruiting
NCT06583395 2024-11-01
QUANTUM
VitaMed Research LLC
Enrolling by invitation
NCT05851053 2024-05-29
BLOC-II
University Medical Center Groningen
Recruiting
NCT05921279 2023-07-25
UCARE
National University of Ireland, Galway, Ireland
Recruiting
NCT05298072 2022-03-28
Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients
University Hospital, Essen
Unknown
NCT03505164 2021-04-27
The Role of suPAR Biomarker in Blood Samples of Breast Cancer Patients During and Post Doxorubicin Chemotherapy: Causative vs. Predictor
Rush University Medical Center
Completed
NCT03155802 2019-11-01
Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines
Stony Brook University
Unknown
NCT02440620 2019-05-01
CaTOB
Odense University Hospital
Completed
NCT00858039 2014-11-05
CATS
Royal Prince Alfred Hospital, Sydney, Australia
Completed